HighVolumeHDF as standard.
Helixone® has been specially designed to meet the demands of both low-flux and high-flux therapies:
No chemical residuals. Low rinsing volumes. Lower costs.
FX low-flux dialyzers | FX 5 | FX 8 | FX 10 |
---|---|---|---|
Ultrafiltration coefficient (ml/h x mmHg) | 8 | 12 | 14 |
Clearance: QB: (200ml/min) | |||
Urea | 180 | 191 | 193 |
Creatinine | 165 | 178 | 181 |
Phosphate | 141 | 160 | 170 |
Vitamin B12 | 88 | 107 | 121 |
Clearance: QB: (300ml/min) | |||
Urea | 228 | 254 | 261 |
Creatinine | 200 | 225 | 231 |
Phosphate | 164 | 194 | 210 |
Vitamin B12 | 94 | 120 | 138 |
Clearance: QB: (400ml/min) | |||
Urea | 293 | 303 | |
Creatinine | 252 | 260 | |
Phosphate | 213 | 233 | |
Vitamin B12 | 126 | 146 | |
The in vitro performance data were obtained with QD = 500ml/min: QF = 0ml/min; T=37°C (ISO8637) The ultrafiltration coefficients were maintained using human blood, Hct = 32%, protein content 6% |
|||
Effective surface area (m²) | 1.0 | 1.4 | 1.8 |
Blood filling volume (ml) | 54 | 74 | 95 |
Membrane material | Helixone® | ||
Housing material | Polypropylene | ||
Potting compound | Polyurethane | ||
Sterilization method | INLINE steam | ||
Application | HD | ||
FX high-flux dialyzers | FX 40 | FX 50 | FX 60 | FX 80 | FX 100 |
---|---|---|---|---|---|
Ultrafiltration coefficient (ml/h x mmHg) | 20 | 33 | 46 | 59 | 73 |
Clearance: QB: (200ml/min) | |||||
Urea | 170 | 189 | 193 | 197 | |
Creatinine | 144 | 170 | 182 | 189 | |
Phosphate | 138 | 165 | 177 | 185 | |
Vitamin B12 | 84 | 115 | 135 | 148 | |
Inulin | 54 | 76 | 95 | 112 | |
Clearance: QB: (300ml/min) | |||||
Urea | 250 | 261 | 276 | 278 | |
Creatinine | 210 | 230 | 250 | 261 | |
Phosphate | 201 | 220 | 239 | 248 | |
Vitamin B12 | 130 | 155 | 175 | 192 | |
Inulin | 81 | 104 | 125 | 142 | |
Clearance: QB: (400ml/min) | |||||
Urea | 303 | 362 | 331 | ||
Creatinine | 262 | 287 | 304 | ||
Phosphate | 248 | 272 | 284 | ||
Vitamin B12 | 167 | 190 | 213 | ||
Inulin | 109 | 133 | 152 | ||
The in vitro performance data were obtained with QD = 500ml/min: QF = 0ml/min; T=37°C (ISO8637) The ultrafiltration coefficients were maintained using human blood, Hct = 32%, protein content 6% |
|||||
Effective surface area (m²) | 0.6 | 1.0 | 1.4 | 1.8 | 2.2 |
Blood filling volume (ml) | 32 | 53 | 74 | 95 | 116 |
Membrane material | Helixone® | ||||
Housing material | Polypropylene | ||||
Potting compound | Polyurethane | ||||
Sterilization method | INLINE steam | ||||
Application | HD/HDF/HF |
FX hemodiafilters | FX 600 | FX 800 | FX 1000 |
---|---|---|---|
Ultrafiltration coefficient (ml/h x mmHg) | 52 | 63 | 75 |
Clearance: QB: (200ml/min)QF: (0ml/min) | |||
Urea | 196 | 198 | |
Creatinine | 184 | 190 | |
Phosphate | 180 | 184 | |
Vitamin B12 | 141 | 149 | |
Inulin | 101 | 110 | |
Clearance: QB: (300ml/min) QF: (75ml/min) | |||
Urea | 284 | 289 | 290 |
Creatinine | 262 | 271 | 280 |
Phosphate | 254 | 262 | 269 |
Vitamin B12 | 199 | 209 | 211 |
Inulin | 150 | 161 | 164 |
Clearance: QB: (400ml/min) QF: (100ml/min) | |||
Urea | 351 | 361 | 364 |
Creatinine | 313 | 328 | 343 |
Phosphate | 301 | 313 | 325 |
Vitamin B12 | 229 | 241 | 244 |
Inulin | 172 | 185 | 188 |
The in vitro performance data were obtained with QD = 500ml/min: T=37°C (ISO8637) The ultrafiltration coefficients were maintained using human blood, Hct = 32%, protein content 6% |
|||
Effective surface area (m²) | 1.5 | 1.8 | 2.2 |
Wall thickness / inner diameter (µm) | 35/210 | ||
Blood filling volume (ml) | 97 | 118 | 138 |
Membrane material | Helixone® | ||
Housing material | Polypropylene | ||
Potting compound | Polyurethane | ||
Sterilization method | INLINE steam | ||
Application | HD/HDF |
1 Bowry, S.K.: Nano-controlled membrane spinning technology: Regulation of pore size, distribution and morphology of a new polysulfone dialysis membrane. In Hemodialysis Technology (eds: Ronco, C., La Greca, G.) Contributions to Nephrology, Vol. 137: 85-94 (2002
2 Ronco, C., Nissenson, A.R.: Does nanotechnology apply to dialysis? Blood Purification 19: 347-352 (2001)